Tell Me Your Story and I'll Send You This Book


This Says Our Favorite Biotech Is Off to the Races

Shares of Inovio Pharmaceuticals Inc. (NYSE: INO) – a promising biotech we recommended back in February 2013 – jumped as much as 27% to a three-month high of $14.20 yesterday after the company said a new cancer drug met its main goal in a midstage clinical trial.

Inovio’s shares backtracked a bit as the day progressed but still closed 17.6% higher for the session. Inovio shares have advanced 361% since we first told you about them. The stock has generated a peak gain of 456%, making it one of the 31 recommendations we’ve made to you that have doubled or better since we launched Private Briefing in August 2011. (More on that later…)

We just celebrated the year-and-a-half anniversary of the launch of Private Briefing, and we've got a lot to be happy about. We've recommended as many as 66 winners - including two triples, three doubles and five takeovers.

Some of our biggest winners - and their peak gains - include:

  • Pharmacyclics Inc. (Nasdaq: PCYC), up 222%
  • Galapagos NV (PINK ADR: GLPYY), 205%.
  • NQ Mobile (NYSE ADR: NQ), 153%.
  • Sandstorm Inc. (TSE: SSL), 142%.
  • Celldex Therapeutics Inc. (Nasdaq: CLDX), 105%
  • Valero Inc. (NYSE: VLO), 95%
  • HollyFrontier Corp. (NYSE: HFC), 86%.
  • American Railcar Industries Inc. (Nasdaq: ARII), 77%.
  • Accuray Inc. (Nasdaq: ARAY), 72%
  • Pentair Inc. (NYSE: PNR), 67%.
  • CNH Global NV (NYSE ADR: CNH), 67%.
  • Nexen Inc. (NYSE: NXY), 63% and 41% (we recommended it twice);
  • CrossTex Energy Partners (NYSE: XTXI), 53%.
  • Molycorp Inc. (NYSE: MCP), 50%
  • ProShares UltraShort Yen (NYSE: YCS): 45%.
  • Delcath Systems Inc. (Nasdaq: DCTH), 42%.
  • Oiltanking Partners LP (NYSE: OILT), 41%.
  • NXP Semiconductors Inc. (NYSE ADR: NXTI): 41%
  • U.S. Gasoline Fund (NYSE: UGA), 39%.
  • eBay Inc. (Nasdaq: EBAY), 39%.
And we've done more than provide stock tips. Our experts have provided answers to your toughest questions, and we've detailed cutting-edge investment strategies for you. We've provided special research reports with winning picks in biotechnology, mining and digital technology. And we've provided insights about world events - the South China Sea affair and the Cyber-Hacking of America are just two of many - long before those stories hit the mainstream press.

To continue reading, please click here…